IS8808A - Fastskammtaform af olmesartan medoxomili og amiódipíni - Google Patents

Fastskammtaform af olmesartan medoxomili og amiódipíni

Info

Publication number: IS8808A
Authority: IS; Iceland
Prior art keywords: amiodipine; dosage form; solid dosage; olmesartan medoxomil; medoxomil
Prior art date: 2006-09-15

Application number

IS8808A

Other languages

English (en)

Inventor

Wolfgang Bauer

Johann Lichey

Anreas Teubner

Elmar Wadenstorfer

Original Assignee

Daiichi Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-15

Filing date

2009-03-12

Publication date

2009-03-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38754721&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8808(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-03-12 Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd

2009-03-12 Publication of IS8808A publication Critical patent/IS8808A/is

Links

239000002051 C09CA08 - Olmesartan medoxomil Substances 0.000 title 1
UQGKUQLKSCSZGY-UHFFFAOYSA-N Olmesartan medoxomil Chemical compound C=1C=C(C=2C(=CC=CC=2)C2=NNN=N2)C=CC=1CN1C(CCC)=NC(C(C)(C)O)=C1C(=O)OCC=1OC(=O)OC=1C UQGKUQLKSCSZGY-UHFFFAOYSA-N 0.000 title 1
229960001199 olmesartan medoxomil Drugs 0.000 title 1
239000007909 solid dosage form Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)

IS8808A 2006-09-15 2009-03-12 Fastskammtaform af olmesartan medoxomili og amiódipíni IS8808A (is)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US84509006P	2006-09-15	2006-09-15

Publications (1)

Publication Number	Publication Date
IS8808A true IS8808A (is)	2009-03-12

Family

ID=38754721

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8808A IS8808A (is)	2006-09-15	2009-03-12	Fastskammtaform af olmesartan medoxomili og amiódipíni

Country Status (22)

Country	Link
US (2)	US20090175942A1 (is)
JP (1)	JP5344620B2 (is)
AT (1)	AT509493B1 (is)
AU (1)	AU2007297333B2 (is)
BR (1)	BRPI0716893A2 (is)
CH (1)	CH703897B1 (is)
DE (1)	DE212007000063U1 (is)
DK (1)	DK200900369A (is)
FI (1)	FI124122B (is)
GB (1)	GB2454620B (is)
IL (1)	IL197518A0 (is)
IS (1)	IS8808A (is)
MY (1)	MY157716A (is)
NZ (1)	NZ575422A (is)
PT (1)	PT2008032107W (is)
RU (1)	RU2423975C2 (is)
SE (1)	SE0900332L (is)
SK (1)	SK288460B6 (is)
TR (1)	TR200901984T1 (is)
TW (1)	TWI399223B (is)
WO (1)	WO2008032107A1 (is)
ZA (1)	ZA200810616B (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2598449Y2 (ja)	1993-08-06	1999-08-09	株式会社ソミック石川	ボールジョイント
ES2510866T3 (es)	2008-03-13	2014-10-21	Daiichi Sankyo Company, Limited	Mejora de la solubilidad de una preparación que contiene olmesartán medoxomilo
TW201000097A (en) *	2008-05-30	2010-01-01	Daiichi Sankyo Co Ltd	Medicament for the prophylaxis or treament of hypertension
US20120115837A1 (en) *	2009-04-30	2012-05-10	Takeda Pharmaceutical Company Limited	Solid Preparation
SI2538924T1 (sl) *	2010-02-24	2014-09-30	Sanofi-Aventis Deutschland Gmbh	Trdne farmacevtske formulacije ramiprila in amlodipin bezilata in njihova priprava
EP2425859A1 (en) *	2010-08-08	2012-03-07	Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi	Olmesartan formulations
CN102028663B (zh) *	2010-12-14	2011-11-30	北京万生药业有限责任公司	一种稳定的奥美沙坦酯固体制剂
JP6018420B2 (ja) *	2012-06-05	2016-11-02	ニプロ株式会社	アンジオテンシンｉｉ受容体拮抗薬およびサイアザイド系利尿薬を含む医薬組成物
CN103565807B (zh) *	2012-07-25	2015-11-04	天津市汉康医药生物技术有限公司	一种奥美沙坦酯氨氯地平药物组合物
JP5790965B2 (ja) *	2012-10-12	2015-10-07	味の素株式会社	カルシウム拮抗薬／アンジオテンシンｉｉ受容体拮抗薬含有医薬製剤の製造方法
JP5871984B2 (ja) *	2013-04-15	2016-03-01	株式会社三和化学研究所	オルメサルタンメドキソミルを含有する医薬組成物
WO2014188729A1 (ja) *	2013-05-24	2014-11-27	持田製薬株式会社	経口用組成物
EP2883539A1 (en)	2013-12-12	2015-06-17	Sanovel Ilac Sanayi ve Ticaret A.S.	Pharmaceutical combinations of olmesartan and amlodipine
CN104739799B (zh) *	2013-12-27	2018-01-05	辰欣药业股份有限公司	一种用于直接压片的苯磺酸氨氯地平组合物及其片剂制备方法
KR102222917B1 (ko) *	2014-06-25	2021-03-05	한림제약(주)	암로디핀 및 올메사탄 메독소밀을 포함하는 약학 조성물
CN104997778A (zh) *	2015-07-08	2015-10-28	南京正大天晴制药有限公司	一种奥美沙坦酯氨氯地平药物组合物
CN105902510A (zh) *	2015-12-24	2016-08-31	嘉实（湖南）医药科技有限公司	一种奥美沙坦酯氨氯地平复方制剂的制备工艺
MX2021010183A (es)	2019-02-26	2021-09-21	Daewoong Pharmaceutical Co Ltd	Composicion farmaceutica con forma de dosificacion unica para tratar o prevenir la hipertension y la hiperlipidemia.
CN115300476B (zh) *	2022-09-01	2024-04-16	华润双鹤药业股份有限公司	一种药物组合物及其制备方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3025292A (en)		1962-03-13		Reduction of i
DK161312C (da)	1982-03-11	1991-12-09	Pfizer	Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en)	1986-04-04	1986-05-08	Pfizer Ltd	Pharmaceutically acceptable salts
US4772596A (en) *	1986-10-09	1988-09-20	Sankyo Company Limited	Dihydropyridine derivatives, their preparation and their use
US5270317A (en) *	1990-03-20	1993-12-14	Elf Sanofi	N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
US5260285A (en) *	1990-12-07	1993-11-09	Merck & Co., Inc.	Substituted imidazopyridazines as angiotensin II antagonists
US5250521A (en) *	1990-12-07	1993-10-05	Merck & Co., Inc.	Substituted pyrazolopyrimidines as angiotensin II antagonists
US5656650A (en) *	1990-12-14	1997-08-12	Smithkline Beecham Corp.	Angiotensin II receptor blocking compositions
US5616599A (en)	1991-02-21	1997-04-01	Sankyo Company, Limited	Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5238942A (en) *	1991-05-10	1993-08-24	Merck & Co., Inc.	Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
US5492904A (en) *	1991-05-15	1996-02-20	E. I. Du Pont De Nemours And Company	Composition of angiotensin-II receptor antagonists and calcium channel blockers
JPH05967A (ja) *	1991-06-19	1993-01-08	Yamanouchi Pharmaceut Co Ltd	組織プラスミノーゲンアクチベーター含有製剤組成物
US5246944A (en) *	1991-08-13	1993-09-21	Merck & Co., Inc.	Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
FR2688781B1 (fr) *	1992-03-23	1994-07-01	Sanofi Elf	Imidazolines n-substituees par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
US5312820A (en) *	1992-07-17	1994-05-17	Merck & Co., Inc.	Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
US5721263A (en) *	1993-06-07	1998-02-24	Takeda Chemical Industries, Ltd.	Pharmaceutical composition for angiotensin II-mediated diseases
GB9405833D0 (en) *	1994-03-24	1994-05-11	Pfizer Ltd	Separation of the enantiomers of amlodipine
US5952006A (en) *	1995-09-29	1999-09-14	L.A.M. Pharmaceuticals, Llc	Drug preparations for treating impotency
US6251436B1 (en) *	1995-09-29	2001-06-26	L.A.M. Pharmaceutical Corporation	Drug preparations for treating sexual dysfunction
US6036977A (en) *	1995-09-29	2000-03-14	L.A.M. Pharmaceutical Corp.	Drug preparations for treating sexual dysfunction
US5808084A (en) *	1996-02-14	1998-09-15	Pfizer, Inc.	Process for the preparation of 1,4-dihydropyridinedicarboxylic esters
EP0795327A1 (en) *	1996-03-13	1997-09-17	Pfizer Inc.	Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin
US6420412B2 (en) *	1996-03-29	2002-07-16	Smithkline Beecham Corporation	Eprosartan dihydate and a process for its production and formulation
CN1221259C (zh) *	1996-07-15	2005-10-05	三共株式会社	Cs－866、氯沙坦和坎迪沙坦用于制备治疗动脉硬化的药物
DE69807695T2 (de) *	1997-06-27	2003-07-31	Smithkline Beecham Corp., Philadelphia	Eprosartan-monohydrate
US6630498B2 (en) *	1997-08-06	2003-10-07	Smithkline Beecham Corporation	Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation
US20010044584A1 (en) *	1997-08-28	2001-11-22	Kensey Kenneth R.	In vivo delivery methods and compositions
US6558699B2 (en) *	1997-11-17	2003-05-06	Smithkline Beecham Corporation	High drug load immediate and modified release oral dosage formulations and processes for their manufacture
US20030022928A1 (en) *	1998-03-11	2003-01-30	Smithkline Beecham Corporation	Novel compositions of eprosartan
US20020127254A1 (en) *	1998-06-25	2002-09-12	Lavipharm Laboratories Inc.	Devices for local and systemic delivery of active substance and methods of manufacturing thereof
US6204281B1 (en) *	1998-07-10	2001-03-20	Novartis Ag	Method of treatment and pharmaceutical composition
WO2000027397A1 (en) *	1998-11-06	2000-05-18	Glaxo Group Limited	Antihypertensive medicaments containing lacidipine and telmisartan
PL350924A1 (en) *	1999-04-06	2003-02-10	Sepracor Inc	Derivatives of venlafaxine and methods of preparing and using the same
US6395728B2 (en) *	1999-07-08	2002-05-28	Novartis Ag	Method of treatment and pharmaceutical composition
EP1867342A1 (en) *	1999-07-21	2007-12-19	Takeda Pharmaceutical Company Limited	Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
SK2692002A3 (en) *	1999-08-30	2002-07-02	Aventis Pharma Gmbh	Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
US6521647B2 (en) *	2000-04-04	2003-02-18	Pfizer Inc.	Treatment of renal disorders
GB2361185A (en) *	2000-04-10	2001-10-17	Nicholas J Wald	Pharmaceutical formulation for the prevention of cardiovascular disease
DE60128683T2 (de) *	2000-04-11	2008-01-24	Sankyo Co., Ltd.	Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten
DE10018401A1 (de) *	2000-04-13	2001-10-25	Boehringer Ingelheim Pharma	Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
CA2420844A1 (en) *	2000-08-30	2003-02-28	Sankyo Company, Limited	Medicinal compositions for preventing or treating heart failure
EP1353727A2 (en) *	2000-12-01	2003-10-22	Novartis AG	Combinations of an angiotensin receptor antagonist and an anti-hypertensive drugor a statin, for the treatment of sexual dysfunction
US20030138494A1 (en) *	2001-05-15	2003-07-24	L.A.M. Pharmaceutical Corporation	Drug preparations for treating sexual dysfunction
CA2456034A1 (en) *	2001-08-03	2003-02-20	Takeda Chemical Industries, Ltd.	Sustained-release medicines
US6680334B2 (en) *	2001-08-28	2004-01-20	Pfizer Inc	Crystalline material
EP1438027A1 (en) *	2001-10-25	2004-07-21	DepoMed, Inc.	Methods of treatment using a gastric retained losartan dosage
EG24716A (en) *	2002-05-17	2010-06-07	Novartis Ag	Combination of organic compounds
AU2004208615C1 (en) *	2003-01-31	2010-05-13	Daiichi Sankyo Company, Limited	Medicine for prevention of and treatment for arteriosclerosis and hypertension
HUP0301537A3 (en) *	2003-06-03	2005-07-28	Egis Gyogyszergyar Nyilvanosan	Deramcyclane fumarate tablets and process for producing them
US20040265238A1 (en) *	2003-06-27	2004-12-30	Imtiaz Chaudry	Inhalable formulations for treating pulmonary hypertension and methods of using same
WO2005070462A2 (en) *	2004-01-12	2005-08-04	Sepracor, Inc.	Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use
US20060074117A1 (en) *	2004-09-02	2006-04-06	Lilach Hedvati	Purification of olmesartan medoxomil
JP2006176496A (ja) *	2004-11-24	2006-07-06	Freunt Ind Co Ltd	固形剤およびその製造方法
WO2006059217A1 (en) *	2004-12-01	2006-06-08	Ranbaxy Laboratories Limited	Stable solid dosage forms of amlodipine besylate and processes for their preparation
KR20090108739A (ko) *	2005-01-03	2009-10-16	테바 파마슈티컬 인더스트리즈 리미티드	불순물의 양이 감소된 올메사탄 메독소밀
WO2006115834A1 (en) *	2005-04-20	2006-11-02	Merck & Co., Inc.	Angiotensin ii receptor antagonists
TWI407978B (zh) *	2005-06-27	2013-09-11	Sankyo Co	濕粒狀藥物之製備方法
TWI405580B (zh) *	2005-06-27	2013-08-21	Sankyo Co	含有血管收縮素ｉｉ接受器拮抗劑及鈣通道阻斷劑之醫藥調配物
KR20070009851A (ko) *	2005-07-14	2007-01-19	씨제이 주식회사	클로피도그렐 황산수소염 함유 약학 조성물
WO2007031933A2 (en) *	2005-09-12	2007-03-22	Actelion Pharmaceuticals Ltd	Stable pharmaceutical composition comprising a pyrimidine-sulfamide
US20090215744A1 (en) *	2005-11-18	2009-08-27	Astrazeneca Ab	Solid Formulations
JP2007145646A (ja) *	2005-11-28	2007-06-14	Asahi Glass Co Ltd	プレス成型装置及びプレス成型装置の搬送品搬送方法
ES2279715B1 (es) *	2005-12-26	2008-06-01	Laboratorios Lesvi, S.L.	Formulacion oral de olanzapina.

2007
- 2007-09-14 TW TW096134347A patent/TWI399223B/zh active
- 2007-10-12 BR BRPI0716893-4A2A patent/BRPI0716893A2/pt not_active Application Discontinuation
- 2007-10-12 RU RU2009114166/15A patent/RU2423975C2/ru active
- 2007-10-12 SE SE0900332A patent/SE0900332L/sv unknown
- 2007-10-12 DE DE212007000063U patent/DE212007000063U1/de not_active Ceased
- 2007-10-12 AU AU2007297333A patent/AU2007297333B2/en active Active
- 2007-10-12 TR TR2009/01984T patent/TR200901984T1/xx unknown
- 2007-10-12 JP JP2009527899A patent/JP5344620B2/ja active Active
- 2007-10-12 WO PCT/GB2007/003933 patent/WO2008032107A1/en not_active Ceased
- 2007-10-12 PT PT2007003933A patent/PT2008032107W/pt unknown
- 2007-10-12 CH CH00742/08A patent/CH703897B1/de unknown
- 2007-10-12 GB GB0903844A patent/GB2454620B/en active Active
- 2007-10-12 SK SK5021-2009A patent/SK288460B6/sk unknown
- 2007-10-12 NZ NZ575422A patent/NZ575422A/en unknown
- 2007-10-12 AT AT0939307A patent/AT509493B1/de active
- 2007-10-12 MY MYPI20091051A patent/MY157716A/en unknown
2008
- 2008-12-15 ZA ZA200810616A patent/ZA200810616B/xx unknown
2009
- 2009-03-10 IL IL197518A patent/IL197518A0/en unknown
- 2009-03-11 US US12/401,748 patent/US20090175942A1/en not_active Abandoned
- 2009-03-12 IS IS8808A patent/IS8808A/is unknown
- 2009-03-13 FI FI20090094A patent/FI124122B/fi active IP Right Grant
- 2009-03-16 DK DK200900369A patent/DK200900369A/en not_active Application Discontinuation
2015
- 2015-06-09 US US14/734,893 patent/US20160129008A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TW200817052A (en)	2008-04-16
US20090175942A1 (en)	2009-07-09
ZA200810616B (en)	2009-08-26
GB2454620A (en)	2009-05-13
GB0903844D0 (en)	2009-04-22
WO2008032107A1 (en)	2008-03-20
CH703897B1 (de)	2012-04-13
TWI399223B (zh)	2013-06-21
MY157716A (en)	2016-07-15
FI20090094L (fi)	2009-03-13
SE0900332L (sv)	2009-06-12
RU2009114166A (ru)	2010-10-20
JP2011500505A (ja)	2011-01-06
AU2007297333A1 (en)	2008-03-20
IL197518A0 (en)	2009-12-24
DE212007000063U1 (de)	2009-05-14
US20160129008A1 (en)	2016-05-12
TR200901984T1 (tr)	2009-08-21
HK1127282A1 (en)	2009-09-25
JP5344620B2 (ja)	2013-11-20
SK50212009A3 (sk)	2009-06-05
DK200900369A (en)	2009-03-16
AT509493A5 (de)	2011-09-15
SK288460B6 (sk)	2017-03-01
NZ575422A (en)	2011-01-28
PT2008032107W (pt)	2013-07-09
AT509493B1 (de)	2012-01-15
AU2007297333B2 (en)	2010-10-28
BRPI0716893A2 (pt)	2014-05-06
GB2454620B (en)	2011-08-17
FI124122B (fi)	2014-03-31
RU2423975C2 (ru)	2011-07-20

Publication	Publication Date	Title
IS8808A (is)	2009-03-12	Fastskammtaform af olmesartan medoxomili og amiódipíni
DK1931350T3 (da)	2014-02-10	Administration af inhibitorer af dipeptidylpeptidase
DK2124999T3 (da)	2013-01-14	Activin-actrii antagonister og anvendelser til behandling af anæmi
DK2097402T3 (da)	2014-06-30	Makrocykliske inhibitorer af hepatitis c-virus
DK2029746T3 (da)	2012-10-08	Sammensætninger og fremgangsmåder til siRNA-hæmning af angiogenese
DK1924577T3 (da)	2011-05-16	Substituerede benzimidazoler og fremgangsmåder til fremstilling
BRPI0819232A2 (pt)	2016-11-01	composto heterocíclico e composição farmacêutica do mesmo
DK2700786T3 (da)	2019-01-02	Modifikation af overførselspassage
DK3338790T3 (da)	2022-05-09	Oligopeptid-forbindelser og anvendelser deraf
DK2034830T3 (da)	2014-10-27	Anti-vla-1-antistof til behandling af slagtilfælde
EP1991153A4 (en)	2010-07-21	An implant drill
DE112007000593A5 (de)	2008-12-11	Bauwerk aus Einzelbauteilen
EP1990326A4 (en)	2012-04-25	PIEZOELECTRIC CERAMIC COMPOSITION
DK2154966T3 (da)	2013-11-18	Benzimidazoler og farmaceutiske sammensætninger deraf
EP1980541A4 (en)	2011-09-07	CEMENT DISPERSION AGENT
DK1942967T3 (da)	2012-10-22	Fremgangsmåde til dosering af medikamenter
DK1986508T3 (da)	2014-08-18	Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme
DK2246477T3 (da)	2019-10-28	Spunspæl med dobbelt t-form
EP2269965A4 (en)	2013-04-03	PIEZOELECTRIC CERAMICS AND PIEZOELECTRIC CERAMIC COMPOSITION
FI20065834A0 (fi)	2006-12-21	Iskulaite
DK2094079T3 (da)	2013-01-02	Sammensætning til fordrivelse og afskrækkelse af utøj
EP2222662A4 (en)	2011-08-03	INHIBITORS OF KYNURENINE AMINO TRANSFERASE
DK2114424T3 (da)	2021-05-17	Betalain-faststofsammensætninger og fremgangsmåder
DK2231603T3 (da)	2013-06-03	Substituerede 3-hydroxypyridiner og farmaceutiske sammensætninger deraf
DK2089708T3 (da)	2012-12-03	Forudsigelige kræft-immunterapi parametre